Ontario - The Future of Canada’s Biotech Industry

• More than half the country's brand-name pharmaceutical and medical devices industries, and almost half the medical biotechnology industry are located in Ontario.
• Ontario is North America's 3rd largest regional concentration of biotechnology firms and the 6th largest in revenues earned.
• The province's bio-medical sector employs more than 33,000 highly educated people and posted more than $1.0 billion in revenues in 2002.
• The biotechnology sector is built on world-class science and is involved in leading edge research in molecular biology and medical genetics.
• Ontario's pharmaceutical sector employs more than 15,000 talented people and includes global giants like GlaxoSmithKline, Amgen, Biogen, Genzyme, Eli Lilly, Pfizer and home-grown stars like Biovail Corporation, Apotex, and Patheon.
• Ontario has achieved worldwide recognition as a site for clinical trials because of its large and ethnically diverse patient population and a centrally managed public health-care system.
• Ontario's medical devices sector employs more than 19,000 highly educated people and comprises more than 500 manufacturing companies that include global subsidiaries as well as niche-driven domestic companies.
• Ontario's agricultural-biotech / bioproducts sector employs more than 6,000 people, including 700 scientists and invests $166 million annually in agricultural-food research at 12 world-class institutions.
• This sector works closely with the manufacturing sector in the production of bio-chemicals and bio-fuels.
• Ontario ranks in the top three jurisdictions in North America in terms of workforce and R&D expenditures in the agricultural-biotechnology sector.